MYO shows severe financial deterioration with massive revenue spike that appears anomalous alongside dramatically worsening losses, cash burn, and equity destruction.
The 40,000%+ revenue increase to $1B appears to be a data error or extraordinary one-time event, as it's inconsistent with the company's historical scale and worsening operational metrics. The authentic concern is the tripling of cash burn, halving of stockholders' equity, and 151% increase in net losses, indicating severe financial distress for what appears to be a medical device company.
While revenue shows an implausible 40,000% jump to $1B, all other metrics indicate severe deterioration - net losses increased 152% to -$15.6M, operating cash flow worsened 341% to -$14.5M, and stockholders' equity collapsed 54% to $11.4M. Cash reserves declined 42% to $14.1M while total liabilities surged 55% to $27.2M, painting a picture of a company burning through capital at an unsustainable rate despite the reported revenue anomaly. The financial profile suggests significant distress and potential going concern issues regardless of the questionable revenue figure.
Strong top-line growth of 40814.8% — accelerating demand or successful expansion into new markets.
Operating cash flow fell 341.1% — earnings quality concerns; investigate working capital changes and non-cash items.
Net income declined 151.9% — review whether driven by operations, interest costs, or non-recurring items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Liabilities grew 55.4% — significant increase in debt or obligations, assess impact on financial flexibility.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
R&D investment increased 45.5% — signals commitment to future product development, though near-term margin impact.
Cash declined 42% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Capex increased 28.1% — ongoing investment in capacity or infrastructure for future growth.
Current liabilities reduced — improved short-term financial position and working capital health.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →